Categories
Emcure Pharmaceuticals Limited — Updates, 16-05-2026: General Updates
16-05-2026 · 02:57 pm
Emcure's Sanand facility received a US FDA Form 483 with 7 procedural observations following an inspection. The company is addressing these findings and plans to respond to the FDA promptly, highlighting ongoing operational compliance efforts.
No comments yet. Be the first to comment!